市場調查報告書
商品編碼
1532135
全球血管通路裝置市場評估:依產品類型、應用、最終用戶、地區、機會、預測(2017-2031)Vascular Access Devices Market Assessment, By Product Type, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F |
全球血管通路裝置市場規模預計將從2023年的 36.3億美元增至2031年的 57.1億美元,預計2024-2031年年複合成長率為 5.83%。由於疾病負擔增加、住院人數增加和醫療保健系統改善,預計市場在預測期內將以相當大的速度擴張。
血管通路裝置是用來將藥物、液體、血液和營養物質注入血管的插入物。這些裝置包括週邊插入中心靜脈導管(PICC)、中心靜脈導管、植入式輸液港和周邊靜脈導管(PIVC)。隨著醫療服務和醫療器材的不斷發展,血管通路器材在設計、材料和影像技術整合方面也不斷發展。血管通路裝置的進步提高了生物相容性、靈活性,並採用了新材料,改善了患者的治療效果和生活品質。生活方式疾病負擔的增加、技術進步以及微創手術的需求推動了對血管通路裝置的需求不斷成長。製造商一直致力於改進設備設計和材料,以改善患者治療效果並減少併發症。
例如,2024年 5月,Teleflex Incorporated 推出了 Arrow EZ-IO 骨內通路手術托盤,增強了其骨內通路產品組合。它包括骨內通路所需的所有組件,並具有第一個經 FDA 批准的可在無菌環境中使用的電池供電驅動器。此托盤設計用於快速、精確地插入,解決臨床醫生在緊急情況下獲得血管通路時所面臨的挑戰。然而,與長期使用導管相關的風險,例如感染和敗血症,可能會對市場成長帶來挑戰。
慢性病負擔的增加擴大了市場規模
全球慢性病負擔不斷加重,癌症、心血管疾病、泌尿系統疾病等慢性病盛行率不斷上升,需要頻繁、長期的化療、透析和藥物治療。通路裝置的需求,包括中心靜脈導管和周邊靜脈導管。造成負擔增加的另一個因素是越來越多的老年人更容易罹患此類疾病。由於目前的情況,預計未來對血管通路裝置的需求將進一步增加。
例如,美國國立衛生研究院(NIH)估計,50 歲及以上患有至少一種慢性病的成年人數量將從2020年的 71,522,000 人增加到2050年的 142,660,000 人,預計增加 %。據估計,到2060年,將有 4,800 萬人死於與健康相關的嚴重痛苦,佔全球死亡人數的 47%,比2016年的 2,600 萬人增加 87%。其中,83%預計發生在低收入和中等收入國家。根據世界衛生組織(WHO)估計,到2050年,地球上60歲以上的人口將增加一倍,達到21億。
設計改善推動市場需求
血管通路裝置包括中心靜脈導管(CVC)、自體血管動靜脈瘻管(AVF)和人工血管動靜脈瘻管(AVG)。 CVC 尖端和護套設計的創新提高了通暢性和血流速度。 AVF 優於 CVC,因為它們不易凝血和感染,更可靠,並提供充足的血流。透過此類設計改進,AVF 成型設備具有引領市場成長的巨大動力。市場公司尋找機會推出具有增強設計的創新產品。例如,2023年 9月,Laminate Medical Technologies 宣布其 VasQ 外部血管支持(一種用於透析通路的 AVF 形成裝置)已獲得美國 FDA 批准。值得注意的是,在使用 VasQ 的臨床試驗中,80%的患者能夠在開始治療後一年內拔除中心靜脈導管,與傳統 AVF 相比,降低了感染風險。 VasQ 在 AVF 形成過程中從結構上增強血管,促進更好的動脈血流和功能。
本報告研究分析了全球血管通路器材市場,提供市場規模和預測、市場動態、主要參與者的現狀和前景等。
Global vascular access devices market is projected to witness a CAGR of 5.83% during the forecast period 2024-2031, growing from USD 3.63 billion in 2023 to USD 5.71 billion in 2031. With increasing disease burden, rising hospitalization, and an improved healthcare system, the market of vascular access devices is anticipated to expand at a notable pace during the forecast period.
Vascular access devices are insertions used to administer drugs, fluids, blood, and nutrients in blood vessels. These devices include peripherally inserted central catheters (PICCs), central venous catheters, implantable ports, and peripheral intravenous catheters (PIVCs). With the never-ending evolution of healthcare services and medical devices, vascular access devices have evolved in terms of design, material, and integration of imaging technologies in it. Advancements in vascular access devices have improved biocompatibility, flexibility, and the adoption of novel materials, enhancing patient outcomes and quality of life. The rising demand for vascular access devices is driven by the growing burden of lifestyle diseases, technological advancements, and the need for minimally invasive procedures. Manufacturers are consistently working to enhance device design and materials to improve patient outcomes and reduce complications.
For instance, in May 2024, Teleflex Incorporated launched the Arrow EZ-IO Intraosseous Access Procedure Tray, enhancing its intraosseous vascular access portfolio. It includes all necessary components for intraosseous access, featuring the first FDA-cleared battery-powered driver that can be utilized in sterile environments. The tray is designed for quick and precise insertion, addressing the challenges clinicians face in obtaining vascular access during emergencies. However, risks associated with long-term use of catheters, such as infections and sepsis may pose challenges for market growth.
Rising Burden of Chronic Diseases to Increase the Market Size
The chronic disease burden is on a rise globally, owing to the increasing prevalence of chronic diseases, such as cancer, cardiovascular and urological disorders, and others, which necessitates frequent and long-term vascular access for treatments such as chemotherapy, dialysis, and medication administration, thereby driving the demand for various types of vascular access devices, including central venous catheters and peripheral IV catheters. Another factor contributing to the growing burden is the rising geriatric population, highly prone to catching such diseases. With the ongoing scenario, the future demand for vascular access devices is anticipated to increase further.
For instance, the National Institute of Health (NIH), anticipates that the number of adults 50 years and older suffer from at least one chronic disease, which will increase by 99.5% from 71.522 million in 2020 to 142.66 million in 2050. An estimated 48 million people, or 47% of all deaths globally, are expected to die from severe health-related suffering by 2060, an 87% increase from 26 million in 2016. It is anticipated that 83% of these deaths will occur in low and middle-income countries. As per World Health Organization (WHO) estimates, by 2050, there will be twice as many people 60 years or older on the planet with the population of 2.1 billion.
Design Improvements to Drive Market Demand
The established types of vascular access devices include central venous catheters (CVCs), arteriovenous fistulas (AVFs), and arteriovenous grafts (AVGs). Innovations in CVC tip and coating design have improved patency and blood flow rates. AVFs are preferred over CVCs as they are less prone to clotting and infection while providing reliable and adequate blood flow rates. With such design enhancements, the AVF creation devices have significant traction leading to market growth. Market players are taking chances to launch innovative products with enhanced designs. For instance, in September 2023, Laminate Medical Technologies announced that it received US-FDA clearance for its VasQ External Vascular Support device, designed to create AVFs for dialysis access. Notably, 80% of patients in trials using VasQ were able to remove central venous catheters within their first year of treatment, reducing the risk of infection compared to traditional AVFs. The VasQ device provides structural reinforcement to the vessels during AVF creation, promoting better arterial flow and functionality.
Drug Administration Application to Dominate Vascular Access Devices Market Share
The drug administration application of the vascular access devices market is anticipated to cover the highest market share. As these devices provide reliable, long-term access to the bloodstream, which is essential for patients needing frequent or prolonged intravenous therapies, such as chemotherapy or chronic disease management, reducing complications associated with traditional IV lines, such as infections and vein irritation, by minimizing the need for repeated needle sticks. A recent study published in the British Medical Journal in July 2024 examined the effectiveness of vascular access devices (VADs) in reducing infection rates among hospitalized patients. The study concluded that VADs along with specific safety measures reduce the chances of infection.
North America Dominates the Global Vascular Access Devices Market Share
North America is anticipated to hold major market share of the global vascular access devices market. North America's leadership in the demand for vascular access devices is attributed to its advanced healthcare infrastructure, rising prevalence of chronic diseases, technological innovations, supportive regulations, and demographic trends favoring increased healthcare needs. According to the United States Renal Data System 2023 Annual Data Report, published in April 2024, more than 85% of individuals who began hemodialysis used a catheter. Additionally, nearly three-quarters of the United States population started without permanent access, a significant increase from about 65% in 2018. This rise in number clearly shows an increasing consumption of such devices in North America causing it to hold the largest market share among other regions.
Future Market Scenario (2024 - 2031F)
The vascular access devices market has witnessed several remarkable futuristic advancements that are anticipated to shape the future of such devices. These advancements include wearable technology, remote monitoring of atrioventricular flow, use of biocompatible materials for product design, 3D printing technology, image-guided vascular access devices, and others. The USFDA approval of WavelinQ and Ellipsys, two vascular access devices that facilitate the creation of arteriovenous fistulas (AVFs) using minimally invasive techniques has paved a new path for more products in line with endovascular fistula creation. The of the most revolutionary advancement is the image-guided vascular access system, Ultreon 1.0 launched by Abbott in October 2023. This platform uses near-infrared light to provide high-definition, precise imaging from within the blood vessels, allowing the healthcare professional precise access to blood vessels even in the most complex anatomies.
Key Players Landscape and Outlook
The market witnessed some substantial market deals such as acquisitions, regulatory approvals, and product launches to expand the share of key players in the global vascular access devices market. In June 2023, Merit Medical announced two strategic acquisitions totaling USD 132.5 million to enhance its dialysis catheter portfolio. Merit Medical is acquiring dialysis catheters and a sealant system from AngioDynamics for USD 100 million, which complements its biopsy devices by preventing pneumothorax during lung biopsies. Additionally, Merit is purchasing the Surfacer catheter system from Bluegrass Vascular Technologies for USD 32.5 million, which facilitates central venous access.
In November 2023, BD launched the SiteRite 9 Ultrasound System, which is an advanced vascular access ultrasound designed to enhance clinician efficiency in placing peripherally inserted central catheters (PICCs), central venous catheters, and IV lines. SiteRite 9 aims to increase first-attempt insertion success and reduce unnecessary needlesticks, supporting BD's vision of a One-Stick Hospital Stay. The system received 510(k) Clearances in September 2023 and is available in the United States
market.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.